CNTA
Centessa Pharmaceuticals
CNTA
CNTA
40 hedge funds and large institutions have $947M invested in Centessa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
20% less funds holding
Funds holding: 50 → 40 (-10)
63% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 16
Holders
40
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$137M | |
| 2 | +$38.4M | |
| 3 | +$12.1M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$7.18M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$4.99M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$11.1M | |
| 3 | -$7.14M | |
| 4 |
Millennium Management
New York
|
-$3.53M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.89M |